osmundacetone

Also Known As:

(E)-3,4-Dihydroxybenzylideneacetone; (E)-4-(3,4-dihydroxyphenyl)but-3-en-2-one

Networked: 3 relevant articles (1 outcomes, 1 trials/studies)

1.	Neoplasms (Cancer) 06/01/2022 - "Osmundacetone (OSC) is a bioactive phenolic compound isolated from Phellinus igniarius and that was shown to exert cytotoxic effects on cancer cells in our previous work. " 11/08/2023 - "This study aims to explore the potential of Osmundacetone (OSC) as a new treatment for infantile hemangiomas (IH), the most common benign tumors in infancy. "
2.	Hemangioma (Angioma) 11/08/2023 - "This study aims to explore the potential of Osmundacetone (OSC) as a new treatment for infantile hemangiomas (IH), the most common benign tumors in infancy. " 11/08/2023 - "Osmundacetone Inhibits Angiogenesis of Infantile Hemangiomas through Inducing Caspases and Reducing VEGFR2/MMP2."
3.	Reperfusion Injury 11/01/2023 - "Osmundacetone Alleviates Cerebral Ischemia-Reperfusion Injury in Rats."
4.	Brain Ischemia (Cerebral Ischemia) 11/01/2023 - "Osmundacetone Alleviates Cerebral Ischemia-Reperfusion Injury in Rats."
5.	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 06/01/2022 - "Osmundacetone modulates mitochondrial metabolism in non-small cell lung cancer cells by hijacking the glutamine/glutamate/α-KG metabolic axis."